37 min listen
Eli Lilly to Develop RNA Editing Therapies + Study Shows Benefits of Daily Steps
Eli Lilly to Develop RNA Editing Therapies + Study Shows Benefits of Daily Steps
ratings:
Length:
24 minutes
Released:
Sep 15, 2021
Format:
Podcast episode
Description
With RNA being the popular new “it” molecule in genetic research, Ayesha discusses Eli Lilly’s new partnership with biotech company ProQR to develop RNA-based therapeutics in this episode. The $1.5 billion deal will see Lilly leverage ProQR’s proprietary RNA editing platform to develop targets of interest. The team discusses how the success of the mRNA COVID-19 vaccines have heightened interest in RNA-based therapies. The editorial team also talked about a new study that found walking 7,000 steps leads to a decreased risk of premature death among middle-aged adults by 50 to 70 percent. It turns out that the popularized “10,000 steps-a-day for good health” notion is no more than a mere myth as it is not an evidence-based recommendation. The new study provides a basis for the establishment of scientifically-backed guidelines for physical activities like walking.Read the full articles here: Eli Lilly Pursues RNA Editing in New Partnership with ProQRHow Many Steps a Day Should You Actually Be Taking? New Study Shows Less May Be MoreFor more life science and medical device content, visit the Xtalks Vitals homepage.Follow Us on Social MediaTwitter: @Xtalks Instagram: @Xtalks Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured
Released:
Sep 15, 2021
Format:
Podcast episode
Titles in the series (100)
Epigenetic Editing with CRISPR + ADHD in Preschoolers by Xtalks Life Science Podcast